arrow
J

Julia Guzmán-Puche

instituto de salud carlos iii
H指数:14
被引数:1,277

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy of high doses of intravenous fosfomycin for treatment of urinary tract infection caused by KPC carbapenemase-producing Klebsiella pneumoniae : An observational study

大剂量静脉注射磷霉素治疗KPC产碳青霉烯酶肺炎克雷伯菌尿路感染的疗效观察

2025-03-010
OAAI
Proof-of-concept study to quantify changes in intestinal loads of KPC-producing Klebsiella pneumoniae in colonised patients following selective digestive decontamination with oral gentamicin

概念验证研究,用于量化口服庆大霉素进行选择性消化净化后定植患者中产生KPC的肺炎克雷伯菌的肠道负荷变化

2022-09-013
OAAI
Prognostic Significance of the Relative Load of KPC-Producing Klebsiella pneumoniae within the Intestinal Microbiota in a Prospective Cohort of Colonized Patients

在定植患者的前瞻性队列中,肠道微生物群中产生KPC的肺炎克雷伯菌的相对负荷的预后意义

2022-08-315
OAAI
Use of carbapenems in the combined treatment of emerging ceftazidime/avibactam-resistant and carbapenem-susceptible KPC-producing Klebsiella pneumoniae infections: Report of a case and review of the literature

碳青霉烯类药物联合治疗新出现的头孢他啶/阿维巴坦耐药和对碳青霉烯类药物敏感的KPC产肺炎克雷伯菌感染: 病例报告和文献复习

2020-09-0137
OAAI
Risks of Infection and Mortality Among Patients Colonized With Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Validation of Scores and Proposal for Management

肺炎克雷伯菌产碳青霉烯酶肺炎克雷伯菌定植患者的感染和死亡风险: 评分验证和管理建议

2017-11-0891
OAAI
Mortality Associated with Bacteremia Due to Colistin-Resistant Klebsiella pneumoniae with High-Level Meropenem Resistance: Importance of Combination Therapy without Colistin and Carbapenems

耐多粘菌素的肺炎克雷伯菌对美罗培南的高水平耐药导致菌血症的死亡率: 无粘菌素和碳青霉烯类药物联合治疗的重要性

2017-08-0168
OAAI